您当前位置:Biomarkers in Medicine(中文)期刊投稿详细信息
Biomarkers in Medicine

Biomarkers in Medicine Q3

  • 期刊收录:
  • SCIE
  • Scopus
基本信息
  • 期刊ISSN:

    1752-0363

  • 期刊简拼:

    BIOMARK MED

  • 年发文章数:

    83

  • E-ISSN:

    1752-0371

  • Gold OA文章占比

    10.80%

  • 研究文章占比:

    89.16%

  • 是否OA:

    No

  • Jcr分区:

    Q3

  • 中科院分区:

    4区

出版信息
  • 出版商:

    Future Medicine Ltd.

  • 涉及研究方向:

    医学-医学:研究与实验

  • 出版国家:

    ENGLAND

  • 出版语言:

    English

  • 出版周期:

    Bimonthly

  • 出版年份:

    2007

  • 2023-2024最新影响因子:1.9
  • 自引率:5.30%
  • 五年影响因子:2.2
  • JCI期刊引文指标:0.44
  • h-index:37
  • CiteScore:3.80

期刊简介

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.

Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.

As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.

Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.

Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.

《Biomarkers in Medicine》期刊已被查看:

此期刊被最新的JCR期刊SCIE收录

期刊信息

  • 通讯地址
  • FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB
  • 中国科学院《国际期刊预警名单(试行)》名单
  • 2024年02月发布的2024版:不在预警名单中
    2023年01月发布的2023版:不在预警名单中
    2021年12月发布的2021版:不在预警名单中
    2020年12月发布的2020版:不在预警名单中
    此期刊被最新的JCR期刊SCIE收录
  • 审稿速度
  • 收录数据库
  • 是否oa
  • 研究方向
  • 较慢,6-12周
  • SCIE,Scopus
  • No
  • 医学-医学:研究与实验

分区信息

中科院分区
  • 大类学科
  • 分区
  • 小类学科
  • Top期刊
  • 综述期刊
  • 医学
  • 4区
  • MEDICINE
    RESEARCH & EXPERIMENTAL
    医学:研究与实验
WOS分区等级:3区
  • 版本
  • 按学科
  • 分区
  • 影响因子
  • WOS期刊SCI分(2023-2024年最新版)
  • MEDICINE
    RESEARCH & EXPERIMENTAL
  • Q3
  • 1.9
IF值(影响因子)趋势图
年发文量趋势图
自引率趋势图
中科院分区

常见问题

  • SCI 期刊的投稿难度如何?

     我相信各位从事科研的小伙伴,对于“SCI论文发表”都应该或多或少有一些执念。不管是对于硕士博士的毕业,还是科研人员的职称评审、课题申请、职业发展,SCI论文

中国全科医学发文选摘